GT1
Showing 1 - 25 of 2,519
Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)
Not yet recruiting
- Hiv
- BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
-
Amsterdam, NetherlandsThe Amsterdam University Medical Centers
Aug 2, 2023
Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))
Not yet recruiting
- Hiv
- BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
- (no location specified)
May 8, 2023
HIV Trial in United States (N332-GT5 gp140 (IM, Bolus), N332-GT5 gp140 (IM, Fractioned), N332-GT5 gp140 (SC, Bolus))
Not yet recruiting
- HIV
- N332-GT5 gp140 (IM, Bolus)
- +7 more
-
San Francisco, California
- +7 more
Sep 8, 2023
HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))
Active, not recruiting
- HIV-1-infection
- eOD-GT8 60mer mRNA Vaccine (100µg)
-
Kigali, Rwanda
- +1 more
Sep 9, 2022
Advanced Solid Tumor Trial in Brussels (GTAEXS617)
Recruiting
- Advanced Solid Tumor
-
Brussels, BelgiumClinique Universitaires Saint-Luc
Aug 8, 2023
HIV/AIDS Trial in Washington, Seattle (eOD-GT8 60mer + AS01B/ DPBS sucrose/IM, DPBS Sucrose)
Completed
- HIV/AIDS
- eOD-GT8 60mer + AS01B/ DPBS sucrose/IM
- DPBS Sucrose
-
Washington, District of Columbia
- +1 more
May 11, 2022
HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)
Not yet recruiting
- HIV Infections
- sD-NP-GT8 DNA
- +4 more
-
Birmingham, Alabama
- +5 more
Mar 10, 2023
Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)
Recruiting
- Dry Age-related Macular Degeneration
- +6 more
- GT005
-
Saint Petersburg, Florida
- +12 more
Dec 21, 2021
Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,
Recruiting
- Hematologic and Lymphocytic Disorder
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)
Completed
- Chronic Hepatitis C
- Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
- (no location specified)
Jan 15, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)
Active, not recruiting
- Aortic Valve Disease
- Aortic Valve Disorder
- Trifecta GT (Glide Technology) Valve
-
Rochester, Minnesota
- +26 more
Mar 10, 2022
Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)
Completed
- Chronic HCV Infection
- Elbasvir/Grazoprevir Fixed Dose Combination
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Sep 9, 2020
Hepatitis C, Chronic Hepatitis Trial in Melbourne, Barcelona (Daclatasvir, Sofosbuvir)
Terminated
- Hepatitis C
- Chronic Hepatitis
-
Melbourne, Victoria, Australia
- +1 more
Apr 16, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +
Recruiting
- Chronic Hepatitis C Infection
- PR4 + LDV/SOF + ASV 4 wk
- +7 more
-
Beijing, Beijing, China
- +1 more
Aug 27, 2021
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 21, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Obesity Trial in Worldwide (Side-to-side anastomosis duodeno-ileostomy diversion procedure)
Recruiting
- Obesity
- Side-to-side anastomosis duodeno-ileostomy diversion procedure
-
Brussels, Belgium
- +4 more
Apr 4, 2022
Compensated Cirrhosis Trial in Bangkok (Grazaoprevir/Elbasavir, Grazaoprevir/Elbasavir/RBV)
Unknown status
- Compensated Cirrhosis
-
Bangkok, Thailand
- +1 more
Feb 11, 2020
Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +13 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2022